Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome
Authors:
Open Access
- 15 December 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8, 790454
Abstract
Objective: To investigate the prevalence, pattern and risk predictors for dyslipidemia among Chinese women with polycystic ovary syndrome (PCOS).Study Design and Methods: A total of 1,000 women diagnosed as PCOS by modified Rotterdam criteria were enrolled in 27 hospitals across China in a randomized controlled trial. Anthropometric, metabolic parameters, sex hormone, and lipid levels were measured at the baseline visit. Dyslipidemia was defined according to total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) level. Independent t-test and logistic regression were used to identify predictors for dyslipidemia. Area under the receiver operating characteristic curve (AUC) was calculated.Results: A total of 41.3% of the women had dyslipidemia, and the prevalence of abnormal TC, LDL-C, HDL-C, and TG were 8.6, 9.1, 26.9, and 17.5%, respectively. Logistic regression found that age, waist circumference, insulin, follicle-stimulating hormone, and sex hormone-binding globulin were independent predictors for dyslipidemia. When combining these predictors, the AUC was 0.744. The cut-off points were age >28.5 years, waist circumference >86.5 cm, insulin >96.0 pmol/L, follicle-stimulating hormone Conclusion: Dyslipidemia was common in Chinese women with PCOS, and low HDL-C level was the predominant lipid abnormality. Age, waist circumference, follicle-stimulating hormone, insulin and sex hormone-binding globulin were predictive for dyslipidemia among Chinese women with PCOS.Keywords
This publication has 41 references indexed in Scilit:
- Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring systemEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2012
- Lipid levels in polycystic ovary syndrome: systematic review and meta-analysisFertility and Sterility, 2011
- HDL and cardiovascular disease: atherogenic and atheroprotective mechanismsNature Reviews Cardiology, 2011
- Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictorsGynecological Endocrinology, 2010
- Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesHuman Molecular Genetics, 2009
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and MenNew England Journal of Medicine, 2009
- High-density lipoprotein metabolism and the human embryoHuman Reproduction Update, 2009
- Subendothelial Lipoprotein Retention as the Initiating Process in AtherosclerosisCirculation, 2007
- Triglycerides and the Risk of Coronary Heart DiseaseCirculation, 2007
- Post-heparin lipolytic enzyme activities, sex hormones and sex hormone-binding globulin (SHBG) in men and women: The HERITAGE Family StudyAtherosclerosis, 2003